HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vincenzo Micale Selected Research

methylazoxymethanol

1/2021Interacting effects of the MAM model of schizophrenia and antipsychotic treatment: Untargeted proteomics approach in adipose tissue.
11/2020Metabolic profile of methylazoxymethanol model of schizophrenia in rats and effects of three antipsychotics in long-acting formulation.
10/2017A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia.
7/2017Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia.
1/2017Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vincenzo Micale Research Topics

Disease

14Schizophrenia (Dementia Praecox)
10/2022 - 10/2013
5Mood Disorders (Mood Disorder)
04/2013 - 04/2008
3Cognitive Dysfunction
10/2022 - 01/2019
3Psychotic Disorders (Schizoaffective Disorder)
12/2021 - 04/2014
2Body Weight (Weight, Body)
11/2020 - 06/2006
2Substance-Related Disorders (Drug Abuse)
07/2017 - 01/2014
2Alzheimer Disease (Alzheimer's Disease)
06/2010 - 11/2007
2Neurodegenerative Diseases (Neurodegenerative Disease)
06/2010 - 11/2007
2Amnesia (Dissociative Amnesia)
11/2006 - 09/2003
1AIDS-Related Complex (ARC)
09/2021
1Insulin Resistance
01/2021
1Neurobehavioral Manifestations
01/2020
1Obesity
01/2019
1Mental Disorders (Mental Disorder)
10/2013
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
05/2012
1Anhedonia
01/2011
1Epilepsy (Aura)
10/2009
1Seizures (Absence Seizure)
10/2009
1Parkinsonian Disorders (Parkinsonism)
02/2009
1Huntington Disease (Huntington's Disease)
11/2007
1Multiple Sclerosis
11/2007
1Decapitation
09/2005
1Memory Disorders (Memory Loss)
09/2003

Drug/Important Bio-Agent (IBA)

7EndocannabinoidsIBA
10/2022 - 11/2007
6CannabinoidsIBA
01/2021 - 09/2003
5Dopamine (Intropin)FDA LinkGeneric
01/2021 - 02/2009
5Antipsychotic Agents (Antipsychotics)IBA
01/2021 - 10/2013
5methylazoxymethanolIBA
01/2021 - 01/2017
4Methylazoxymethanol AcetateIBA
10/2022 - 01/2019
4Pharmaceutical PreparationsIBA
01/2021 - 05/2012
4Acetates (Acetic Acid Esters)FDA Link
01/2021 - 01/2017
3AM 251 (AM251)IBA
10/2022 - 01/2018
3CannabidiolIBA
01/2021 - 01/2019
3Haloperidol (Haldol)FDA LinkGeneric
01/2021 - 01/2019
3Messenger RNA (mRNA)IBA
01/2021 - 01/2020
3CB1 Cannabinoid Receptor (CB1 Receptor)IBA
01/2019 - 09/2003
2Antimitotic AgentsIBA
10/2022 - 01/2019
2Dronabinol (THC)FDA LinkGeneric
12/2021 - 01/2019
2Proteins (Proteins, Gene)FDA Link
09/2021 - 01/2021
2Risperidone (Risperdal Consta)FDA LinkGeneric
01/2021 - 11/2020
2Olanzapine (Zyprexa)FDA Link
01/2021 - 11/2020
1Lim KinasesIBA
09/2021
1Fatty Acids (Saturated Fatty Acids)IBA
01/2021
1Nucleic AcidsIBA
01/2021
1Glucagon-Like Peptide 1 (GLP 1)IBA
11/2020
1Glucagon (Glukagon)FDA Link
11/2020
1Hormones (Hormone)IBA
11/2020
1LipidsIBA
11/2020
1GhrelinIBA
11/2020
1LeptinIBA
11/2020
1Dopamine D3 ReceptorsIBA
01/2020
1RimonabantIBA
01/2019
1Biomarkers (Surrogate Marker)IBA
10/2017
1Methamphetamine (Desoxyn)FDA LinkGeneric
07/2017
1KetamineFDA LinkGeneric
07/2017
1Antidepressive Agents (Antidepressants)IBA
10/2013
1Therapeutic UsesIBA
04/2013
1trimethyltin chlorideIBA
05/2012
1Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
05/2012
1SolutionsIBA
01/2011
1PicrotoxinIBA
10/2009
1Diazepam (Valium)FDA LinkGeneric
10/2009
1Anticonvulsants (Antiepileptic Drugs)IBA
10/2009
1SR 48968 (saredutant)IBA
09/2008
1TachykininsIBA
09/2008
1CholesterolIBA
06/2008
1AutoreceptorsIBA
04/2008
1Neurotransmitter Agents (Neurotransmitter)IBA
11/2007
1amyloid beta-protein (1-42)IBA
11/2006
1GalaninIBA
11/2006
11-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA
11/2006
1Serotonin (5 Hydroxytryptamine)IBA
11/2006
15- (8- amino- 7- chloro- 2,3- dihydro- 1,4- benzodioxin- 5- yl)- 3- (1- (2- phenylethyl)- 4- piperidinyl)- 1,3,4- oxadiazol- 2(3H)- oneIBA
11/2006
15-HT4 Serotonin ReceptorsIBA
11/2006
1Benzene (Benzole)IBA
06/2006
1CorticosteroneIBA
09/2005
1Amyloid beta-PeptidesIBA
09/2003

Therapy/Procedure

2Self Administration (Administration, Self)
07/2017 - 01/2014
1Therapeutics
04/2013
1Drug Therapy (Chemotherapy)
05/2012